Spire Wealth Management Sorrento Therapeutics, Inc. Transaction History

Spire Wealth Management

  • $2.95 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022
BUY
$1.24 - $2.33 $6,200 - $11,650
5,000 Added 33.33%
20,000 $40,000
Q1 2022

Apr 18, 2022
SELL
$2.0 - $4.9 $120 - $294
-60 Reduced 0.4%
15,000 $35,000
Q2 2021

Jul 26, 2021
SELL
$6.35 - $10.0 $28,575 - $45,000
-4,500 Reduced 23.01%
15,060 $146,000
Q1 2021

May 21, 2021
BUY
$7.03 - $16.51 $137,506 - $322,935
19,560 New
19,560 $162,000

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Spire Wealth Management Portfolio

Follow Spire Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Spire Wealth Management with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email